Table 2.
Laboratory tests frequency (%) | |||||||
Anti-tTG | SBB | HLA result | |||||
Patient groups | Positive | Negative | Positive | Negative | Positive | Negative | Notes |
A | – | – | – | – | 3 [8.5%] | 27 [77.1%] | |
B | 29 [82.8%] | 6 [17.1%] | 20 [57.1%] | 3 [8.5%] | 35 [100%] | 0 | |
C | 24 [68%] | 11 [31%] | 3 [8.5%] | 6 [17.1%] | 24 [68%] | 11 [31.4%] | 24 had CD |
D | 9 [25.7%] | 26 [74.2%] | 4 [11.4%] | 0 | 32 [91.4%] | 3 [8.6%] | 9 had CD |
E | – | – | – | – | 9 [25.7%] | 26 [74.2%] | None had CD |
Group A: control; Group B: diagnosed cases of celiac disease; Group C: patients with celiac-like symptoms; Group D: type 1 diabetes patients with celiac-like symptoms; Group E: type 1 diabetes patients.
HLA-typing: alleles detected: HLA-DQA1∗05, DQB1∗02, and/or DQB1∗03:02.
Anti-tTG = anti tissue transglutaminase; CD = celiac disease; SBB = small bowel biopsy.